Post-Market Data Collection Without Overburdening Participants

The trial is over. The product is approved. The headlines fade. But the need for data continues. Post-market studies fill the gap between controlled conditions and the reality of use. They track long term safety, effectiveness in wider populations, and emerging patterns not seen in earlier phases.

‍

But now the context has changed. Participants are not volunteers in a controlled setting. They are real people, living real lives, often with no formal ties to the research team. They might be taking the product for years, or they might have just started. Some may never even realise they are part of a post-market study.

‍

The challenge is collecting meaningful data without making it feel like a burden.

‍

One: Lower the threshold for participation

The more effort required, the less likely people are to stay involved. Make it easy to say yes. Easier still to remain involved. Offer different paths in:

• Email or SMS surveys that take less than a minute
• App-based check-ins with prefilled answers from previous visits
• Passive data collection from devices, with clear opt in and opt out

People will participate if the ask fits their routine.

‍

Two: Respect the change in relationship

During the trial, participants might have had a dedicated coordinator. After approval, the study team fades into the background. That means:

• Messages need to be clearer, since there is no one to clarify them
• Instructions must work for a wider, less trained population
• Feedback matters more, because contact is rare

Make each interaction count. If someone completes a task, acknowledge it. If they skip three in a row, ask why, kindly. If you change the schedule, tell them how it affects their role.

‍

Three: Collect less, but better

This is not the time for long daily diaries. It is the time for focused insight. Pick a few signals and follow them well.

Ask simple but consistent questions:

• Are symptoms stable
• Has anything unexpected occurred
• Are people using the product as intended

Keep questions short. Repetition is fine if it is meaningful. If someone has not reported a problem in six months, ask again—but do not require ten extra clicks to do it.

‍

Four: Build systems that allow drop in and drop out

People’s availability changes. They uninstall apps. They change numbers. The most valuable studies allow participants to:

• Rejoin without friction
• Update contact details with minimal steps
• Pause involvement without being excluded

Design for gaps. Build in a path back. Even partial data helps if you know what is missing and why.

‍

Five: Let people know what their data does

Even at a distance, people care about outcomes. If they are contributing to safety monitoring, or helping researchers understand rare effects, say so.

Consider small updates:

• A message showing how many participants have shared data this month
• A chart with anonymised trends
• A reminder that their participation improves future treatment decisions

‍

This does not need to be marketing. It needs to be honest. Data has weight. People want to know that theirs is being used with care.

‍

‍

Post-market does not mean post-relationship

It just means the relationship looks different. Quieter. Less formal. More fragile, maybe. But still worth building. If the product is good and the communication is clear, people will share. They just need to be asked well. And when they are, the picture that emerges is not just a final chapter. It is the part that happens when medicine leaves the trial and enters the world.

‍